Erin Cobain is an Oncology physician affiliated with University of Michigan. OpenAlex indexes 66 publications with 1,734 citations (h-index 14); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer
Sponsor: University of Michigan Rogel Cancer Center
- Tissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast Cancer
Sponsor: University of Michigan
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- NovartisProgram year20255 paymentsResearch$407,988openpaymentsdata.cms.gov ↗
- AstraZenecaProgram year20251 paymentResearch$21,042openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Navigating Treatment Decisions in Early-Stage Hormone Receptor–Positive Breast Cancer
American Society of Clinical Oncology Educational Book
2026 - Association of the 70-gene assay and homologous recombination deficiency in patients with high risk 2 breast cancers.
Journal of Clinical Oncology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Max Wicha, MD
University of Michigan
Eva Feldman, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
Joshua Ehrlich, MD
University of Michigan
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”